Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-04

FDA Approved: OMEPRAZOLE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for omeprazole submitted by Zydus Lifesciences Limited. The exact scope of the supplement (such as labeling changes or e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)